Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents
Chronic Hepatitis C is a global epidemic, and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus (HCV) infection. This article elaborates on the management method and individualized treatment regimens for special populations, including children with hepa...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-02-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8746 |
id |
doaj-102f0209bcab40b88aa10a35914cfb7c |
---|---|
record_format |
Article |
spelling |
doaj-102f0209bcab40b88aa10a35914cfb7c2020-11-25T00:18:30ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562018-02-0134224224510.3969/j.issn.1001-5256.2018.02.005Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents LI Junli0Department of Infectious Diseases, Henan Provincial People′s Hospital, Zhengzhou 450000, ChinaChronic Hepatitis C is a global epidemic, and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus (HCV) infection. This article elaborates on the management method and individualized treatment regimens for special populations, including children with hepatitis C, patients with renal injury, patients undergoing liver transplantation, patients with liver cirrhosis, patients with HIV infection, and patients with acute hepatitis C. http://www.lcgdbzz.org/qk_content.asp?id=8746 |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
LI Junli |
spellingShingle |
LI Junli Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents Linchuang Gandanbing Zazhi |
author_facet |
LI Junli |
author_sort |
LI Junli |
title |
Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents |
title_short |
Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents |
title_full |
Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents |
title_fullStr |
Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents |
title_full_unstemmed |
Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents |
title_sort |
management and treatment of special populations with hepatitis c virus infection in the era of direct-acting antiviral agents |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2018-02-01 |
description |
Chronic Hepatitis C is a global epidemic, and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus (HCV) infection. This article elaborates on the management method and individualized treatment regimens for special populations, including children with hepatitis C, patients with renal injury, patients undergoing liver transplantation, patients with liver cirrhosis, patients with HIV infection, and patients with acute hepatitis C. |
url |
http://www.lcgdbzz.org/qk_content.asp?id=8746 |
work_keys_str_mv |
AT lijunli managementandtreatmentofspecialpopulationswithhepatitiscvirusinfectionintheeraofdirectactingantiviralagents |
_version_ |
1725376182300442624 |